Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Silybin, a new iron-chelating agent.

M Borsari1, C Gabbi, F Ghelfi

  • 1Dipartimento di Chimica, Università di Modena, Via Campi 183-41100 Modena, Italy.

Journal of Inorganic Biochemistry
|June 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

ESMO real world data and digital oncology·2026
Same author

Radiomics-based ultrasOund Model for differentiating Uterine Sarcomas from leiomyomas (ROMUS): a retrospective pilot Multicenter Italian Trials in Ovarian Cancer (MITO) study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025
Same author

Detection and biochemical characterization of circulating proteasomes in dog plasma.

Research in veterinary science·2023
Same author

Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.

Cancer medicine·2023
Same author

Design of a custom-made device for real-time optical measurement of differential mineral concentrations in three-dimensional scaffolds for bone tissue engineering.

Royal Society open science·2022

Silybin, a natural compound, effectively chelates iron (Fe(III)), indicating its potential for treating iron overload disorders like Cooley's anemia.

Area of Science:

  • Natural product chemistry
  • Coordination chemistry
  • Biochemistry

Background:

  • Silybin, a flavolignan from Silibum marianum, exhibits antioxidant and free radical scavenging properties.
  • Previous suggestions indicated silybin's potential as an iron chelator.

Purpose of the Study:

  • To investigate the complexation and protonation equilibria of the ferric complex of silybin.
  • To explore silybin's iron-binding capabilities under various conditions.
  • To evaluate silybin's potential in chelation therapy for chronic iron overload.

Main Methods:

  • Potentiometric, spectrophotometric, and electrochemical techniques were employed.
  • Proton Nuclear Magnetic Resonance (1H NMR) spectroscopy studied silybin-Ga(III) complex formation.

Related Experiment Videos

  • Mass spectrometry and infrared spectroscopy confirmed complex structures.

    • Main Results:

    • Silybin demonstrates the ability to bind ferric iron (Fe(III)) even at acidic pH.
    • The formation of different ternary complexes was observed with increasing methoxide ion concentration.
    • Stability constants for these complexes were successfully calculated.

    Conclusions:

    • Silybin effectively chelates iron, supporting its potential therapeutic role.
    • This study highlights silybin's promise for chelation therapy in conditions like Cooley's anemia.
    • Further research into silybin-based iron chelation is warranted.